SG Americas Securities LLC reduced its position in Humana Inc (NYSE:HUM) by 29.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,183 shares of the insurance provider’s stock after selling 12,748 shares during the period. SG Americas Securities LLC’s holdings in Humana were worth $7,717,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Cornerstone Advisors Inc. lifted its position in shares of Humana by 9.9% during the third quarter. Cornerstone Advisors Inc. now owns 388 shares of the insurance provider’s stock worth $99,000 after purchasing an additional 35 shares during the last quarter. Lindbrook Capital LLC lifted its position in shares of Humana by 12.0% during the third quarter. Lindbrook Capital LLC now owns 327 shares of the insurance provider’s stock worth $84,000 after purchasing an additional 35 shares during the last quarter. Regentatlantic Capital LLC lifted its position in shares of Humana by 0.4% during the second quarter. Regentatlantic Capital LLC now owns 9,617 shares of the insurance provider’s stock worth $2,551,000 after purchasing an additional 42 shares during the last quarter. Ballentine Partners LLC lifted its position in shares of Humana by 2.5% during the third quarter. Ballentine Partners LLC now owns 1,751 shares of the insurance provider’s stock worth $448,000 after purchasing an additional 42 shares during the last quarter. Finally, Cim Investment Mangement Inc. lifted its position in shares of Humana by 4.3% during the second quarter. Cim Investment Mangement Inc. now owns 1,125 shares of the insurance provider’s stock worth $298,000 after purchasing an additional 46 shares during the last quarter. 92.93% of the stock is owned by institutional investors.
In other Humana news, insider Brian P. Leclaire sold 7,239 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $289.70, for a total value of $2,097,138.30. Following the sale, the insider now owns 12,994 shares in the company, valued at $3,764,361.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.54% of the stock is currently owned by company insiders.
Several equities research analysts recently weighed in on HUM shares. Berenberg Bank reiterated a “buy” rating on shares of Humana in a research note on Monday, October 21st. SunTrust Banks increased their price objective on shares of Humana to $335.00 and gave the stock a “hold” rating in a research note on Thursday. They noted that the move was a valuation call. UBS Group increased their price objective on shares of Humana from $266.00 to $317.00 and gave the stock a “neutral” rating in a research note on Thursday, August 1st. Deutsche Bank started coverage on shares of Humana in a research note on Thursday, September 12th. They set a “hold” rating and a $300.00 price objective on the stock. Finally, Cantor Fitzgerald upgraded shares of Humana from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $300.00 to $345.00 in a research note on Monday, August 12th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fourteen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $322.63.
Shares of NYSE:HUM traded up $2.44 during trading hours on Friday, hitting $317.58. The stock had a trading volume of 1,173,375 shares, compared to its average volume of 1,220,728. The stock’s fifty day simple moving average is $277.48 and its 200 day simple moving average is $270.93. Humana Inc has a 1-year low of $225.65 and a 1-year high of $342.03. The firm has a market capitalization of $39.82 billion, a price-to-earnings ratio of 21.83, a PEG ratio of 1.27 and a beta of 0.85. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.75 and a current ratio of 1.75.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 6th. The insurance provider reported $5.03 EPS for the quarter, beating the consensus estimate of $4.58 by $0.45. Humana had a net margin of 4.13% and a return on equity of 22.47%. The company had revenue of $16.24 billion for the quarter, compared to analyst estimates of $16.15 billion. During the same quarter last year, the business earned $4.58 earnings per share. Humana’s revenue was up 14.3% compared to the same quarter last year. As a group, research analysts anticipate that Humana Inc will post 17.75 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.55 dividend. The ex-dividend date is Monday, December 30th. This represents a $2.20 annualized dividend and a dividend yield of 0.69%. Humana’s payout ratio is currently 15.12%.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Article: What is a Derivative?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.